Jazz Pharmaceuticals PLC (JAZZ)
125.10
+5.86
(+4.91%)
USD |
NASDAQ |
Nov 21, 16:00
126.97
+1.87
(+1.49%)
Pre-Market: 08:18
Jazz Pharmaceuticals Gross Profit Margin (Quarterly): 89.42% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 89.42% |
| June 30, 2024 | 89.27% |
| March 31, 2024 | 89.41% |
| December 31, 2023 | 89.40% |
| September 30, 2023 | 89.49% |
| June 30, 2023 | 89.81% |
| March 31, 2023 | 85.59% |
| December 31, 2022 | 82.78% |
| September 30, 2022 | 85.79% |
| June 30, 2022 | 86.69% |
| March 31, 2022 | 85.83% |
| December 31, 2021 | 84.82% |
| September 30, 2021 | 82.67% |
| June 30, 2021 | 84.15% |
| March 31, 2021 | 93.39% |
| December 31, 2020 | 92.46% |
| September 30, 2020 | 92.99% |
| June 30, 2020 | 95.02% |
| March 31, 2020 | 94.64% |
| December 31, 2019 | 93.92% |
| September 30, 2019 | 94.16% |
| June 30, 2019 | 94.82% |
| March 31, 2019 | 93.41% |
| December 31, 2018 | 94.47% |
| September 30, 2018 | 94.34% |
| Date | Value |
|---|---|
| June 30, 2018 | 93.06% |
| March 31, 2018 | 92.37% |
| December 31, 2017 | 94.21% |
| September 30, 2017 | 92.42% |
| June 30, 2017 | 92.73% |
| March 31, 2017 | 93.33% |
| December 31, 2016 | 91.51% |
| September 30, 2016 | 93.50% |
| June 30, 2016 | 93.71% |
| March 31, 2016 | 93.02% |
| December 31, 2015 | 92.95% |
| September 30, 2015 | 91.67% |
| June 30, 2015 | 93.46% |
| March 31, 2015 | 90.85% |
| December 31, 2014 | 91.22% |
| September 30, 2014 | 91.20% |
| June 30, 2014 | 89.46% |
| March 31, 2014 | 87.48% |
| December 31, 2013 | 89.12% |
| September 30, 2013 | 89.55% |
| June 30, 2013 | 87.98% |
| March 31, 2013 | 86.13% |
| December 31, 2012 | 85.98% |
| September 30, 2012 | 81.41% |
| June 30, 2012 | 90.11% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
82.67%
Minimum
Sep 2021
95.02%
Maximum
Jun 2020
88.88%
Average
89.41%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Avadel Pharmaceuticals PLC | 87.70% |
| Alkermes PLC | 83.31% |
| Medtronic PLC | 64.94% |
| Perrigo Co PLC | 37.19% |
| Iterum Therapeutics PLC | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 12.28% |
| Return on Assets | 4.02% |
| Return on Invested Capital | 4.84% |
| Profit Margin (Quarterly) | 20.38% |
| Operating Margin (Quarterly) | 24.67% |
| Return on Net Operating Assets | 5.05% |